On the contrary, CD8+ lymphocytes were important component of cell-mediated immunity and tumor-infiltrating CD8+ lymphocytes have been proven to have anti-tumor activity in ovarian (36), colorectal (37) and esophageal tumors (38). Here, CD8A is linked to neoplasm.